Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy ...

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

Can Ozempic and similar drugs cause muscle and bone loss? Discover how to maintain your health while achieving weight loss ...

GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...

The lawsuit was brought against the FDA after the agency declared an end to the shortage that allowed pharmacies to sell compound versions of the popular weight loss drugs, but Eli Lilly said it ...

Due to weather advisories and for the safety of patients, the following Margaret Mary Health facilities will be closed until ...

Researchers at a University of Michigan lab have developed a “first-of-its-kind” blood test to detect head and neck cancers ...

Trans Rights To Be Marquee Fight For House Republicans Believing voters in the 2024 elections rejected Democrats’ more inclusive positions on transgender rights, Republicans appear ready in 2025 to ...